antibiotics (mean 78 vs. 91, P = 0.01), driven by the increase in piperacillin/tazobactam utilization.
"minor nuisance" (46%) or "occasionally burdensome" (27%). Most (55%) felt it had no impact on their consideration of ABX appropriateness.
Conclusion. With the exception of prophylaxis, the accuracy of ABX IND documented during order entry was sufficiently reliable to assist stewardship efforts. Although IND documentation is perceived as only a minor burden, prescribers attributed minimal beneficial effect on ABX prescribing.
Disclosures. Methods. Antibiotic orders with a documented indication of "genitourinary (GU)-cystitis" were retrospectively reviewed in adult, non-neutropenic hospitalized patients at three community hospitals from April to June 2017. Accuracy of the documented indication was evaluated via chart review. Patient demographics, initial antibiotic selection, ordering service, treatment duration, and infectious diseases (ID) involvement were also evaluated. Data pertaining to the appropriate diagnosis of cystitis was adjudicated by an ID physician.
Results. A total of 122 patients treated for "GU-cystitis" were reviewed (66% female, median age 77 years). Overall, only 25% of orders reviewed were consistent with cystitis per documentation in the chart. However, 42% of patients had evidence of a GU infection other than cystitis. Only 16% of patients possessed criteria for diagnosis of cystitis when adjudicated by an ID physician after additional information was obtained from the chart. About 20% of patients had evidence of asymptomatic bacteriuria and 10% of patients did not have a urinalysis and/or urine culture. The majority of patients were initially prescribed a cephalosporin (70%) or fluoroquinolone (16%). The emergency department was responsible for 52% of orders labeled as cystitis.
Conclusion. Cystitis was inaccurately selected as the indication for most of the orders reviewed. To improve accuracy, minimize provider fatigue and provide better utility to ASPs, the list of available indications should be simplified to include broader terms (i.e., GU instead of GU-cystitis). Appropriate diagnosis and treatment of cystitis remains a challenge and a target for improvement for ASPs.
Disclosures. All authors: No reported disclosures. Background. Attainable, low-resource antimicrobial stewardship (AMS) interventions, "low-hanging fruit" can be facilitated by electronic medical record (EMR) enhancements. Oral (PO) fluoroquinolone (FQ) or tetracycline (TCN) coadministration with di-and tri-valent cations reduces antibiotic absorption by up to 75%, is common, and may represent low-hanging fruit. We evaluated concomitant administration and outcomes in a five hospital system before and after an EMR medication safety improvement.
More Low-hanging Fruit: Antibiotic Chelation Drug Interactions
Methods. IRB approved quasi-experiment, emergency (ED) visits and hospital admissions September 2016-February 2017 and September 2017-February 2018. Standard of Care: cations were scheduled 0900 and 2100; FQ and TCN administration instructions stated: "Administer at least 2 hours before or 6 hours after (cations). " Intervention: April 2017 EMR change in the default timing of FQ and TCN to 0630 and 1530 with pharmacy and nurse education. Primary endpoint: coadministration, defined as administration of PO product containing calcium, magnesium, iron, or phosphate binder 2 hours before or 6 hours after PO doxycycline, ciprofloxacin, or moxifloxacin.
Results. A total of 4,414 and 5,231 patients, representing 4,887 and 5,781 encounters, received PO FQ or TCN pre-and post-intervention, respectively. Average age (years) pre: 62.1, post: 61.3. Respiratory infection most common (25% pre, 27% post) followed by genitourinary (13% pre, 12% post). Concomitant administration: 3629/17,702, 20.5% pre vs. 2,184/20,524, 10 .6% post (P < 0.001), see Table 1 . Median hospital length of stay: 3 (0.3, 6) pre, 2.9 (0.3, 5.8) post. Thirty-day all-cause readmission: 28% pre and 27.2% post.
Conclusion. A system-based change to the EMR was effective to reduce the frequency of FQ and TCN chelation interactions by half and represents a low-hanging fruit strategy for AMS programs. Our institution has subsequently employed this strategy to reduce chelation interactions with HIV integrase inhibitors.
